Finland vs Netherlands: The number of people with susceptibility test result for rifampicin
Finland
86.14
in 2021
Netherlands
86.26
in 2021
Finland rank
83rd
Netherlands rank
82nd
The number of people with susceptibility test result for rifampicin over time
- Finland
- Netherlands
How they compare
Netherlands currently reports 86.26 against 86.14 in Finland, a difference of 0.12.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Netherlands ahead.
Finland ranks 83rd and Netherlands ranks 82nd of 146 countries.
Finland has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Finland | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 93.15 | 88.98 | 4.17 | Finland |
| 2020s | 91.15 | 86.86 | 4.29 | Finland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Finland or Netherlands?
- Netherlands, at 86.26 against 86.14 in Finland as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Finland and Netherlands?
- 0.12, with Netherlands ahead.
- How many years of comparable data are there for Finland and Netherlands?
- 5 years are reported by both, from 2017 to 2021.
- How do Finland and Netherlands rank globally for the number of people with susceptibility test result for rifampicin?
- Finland ranks 83rd and Netherlands ranks 82nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.